GLABF
Price
$0.29
Change
-$0.08 (-21.62%)
Updated
Sep 2 closing price
Capitalization
23.83M
VYGR
Price
$4.24
Change
+$0.36 (+9.28%)
Updated
Sep 5 closing price
Capitalization
235.19M
72 days until earnings call
Interact to see
Advertisement

GLABF vs VYGR

Header iconGLABF vs VYGR Comparison
Open Charts GLABF vs VYGRBanner chart's image
GEMINA LABORATORIES
Price$0.29
Change-$0.08 (-21.62%)
Volume$2.5K
Capitalization23.83M
Voyager Therapeutics
Price$4.24
Change+$0.36 (+9.28%)
Volume$1.37M
Capitalization235.19M
GLABF vs VYGR Comparison Chart in %
Loading...
GLABF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLABF vs. VYGR commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLABF is a Hold and VYGR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (GLABF: $0.29 vs. VYGR: $4.24)
Brand notoriety: GLABF and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLABF: 23% vs. VYGR: 192%
Market capitalization -- GLABF: $23.83M vs. VYGR: $235.19M
GLABF [@Biotechnology] is valued at $23.83M. VYGR’s [@Biotechnology] market capitalization is $235.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLABF’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 2 green FA rating(s).

  • GLABF’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 2 green, 3 red.
According to our system of comparison, VYGR is a better buy in the long-term than GLABF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLABF’s TA Score shows that 3 TA indicator(s) are bullish while VYGR’s TA Score has 5 bullish TA indicator(s).

  • GLABF’s TA Score: 3 bullish, 4 bearish.
  • VYGR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VYGR is a better buy in the short-term than GLABF.

Price Growth

GLABF (@Biotechnology) experienced а -21.42% price change this week, while VYGR (@Biotechnology) price change was +26.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

VYGR is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VYGR($235M) has a higher market cap than GLABF($23.8M). VYGR YTD gains are higher at: -25.220 vs. GLABF (-46.979). GLABF has higher annual earnings (EBITDA): -3.73M vs. VYGR (-119.18M). VYGR has more cash in the bank: 43.9M vs. GLABF (15K). GLABF has less debt than VYGR: GLABF (244K) vs VYGR (40.2M). VYGR has higher revenues than GLABF: VYGR (42.6M) vs GLABF (10.9K).
GLABFVYGRGLABF / VYGR
Capitalization23.8M235M10%
EBITDA-3.73M-119.18M3%
Gain YTD-46.979-25.220186%
P/E RatioN/A6.00-
Revenue10.9K42.6M0%
Total Cash15K43.9M0%
Total Debt244K40.2M1%
FUNDAMENTALS RATINGS
VYGR: Fundamental Ratings
VYGR
OUTLOOK RATING
1..100
37
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
10
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLABFVYGR
RSI
ODDS (%)
Bullish Trend 3 days ago
50%
Bearish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
58%
Bearish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
41%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
55%
Bullish Trend 3 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
54%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
54%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
GLABF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IFCZF201.101.21
+0.61%
Intact Financial Corp.
COLDF0.17N/A
N/A
Cardno Ltd.
SEBC24.14N/A
N/A
Southeastern Banking Corp.
SPPJY1.68N/A
N/A
Sappi Ltd.
PTRRY6.88N/A
N/A
PRIO S A

GLABF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLABF has been loosely correlated with ELVAF. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if GLABF jumps, then ELVAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLABF
1D Price
Change %
GLABF100%
N/A
ELVAF - GLABF
36%
Loosely correlated
N/A
TNFA - GLABF
29%
Poorly correlated
-8.59%
IDRSF - GLABF
23%
Poorly correlated
N/A
VYGR - GLABF
22%
Poorly correlated
+9.28%
ENTO - GLABF
8%
Poorly correlated
+1.89%
More